Index
1 Market Overview of CRISPR & Cas9
1.1 CRISPR & Cas9 Market Overview
1.1.1 CRISPR & Cas9 Product Scope
1.1.2 CRISPR & Cas9 Market Status and Outlook
1.2 Global CRISPR & Cas9 Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global CRISPR & Cas9 Market Size by Region (2018-2029)
1.4 Global CRISPR & Cas9 Historic Market Size by Region (2018-2023)
1.5 Global CRISPR & Cas9 Market Size Forecast by Region (2024-2029)
1.6 Key Regions, CRISPR & Cas9 Market Size (2018-2029)
1.6.1 North America CRISPR & Cas9 Market Size (2018-2029)
1.6.2 Europe CRISPR & Cas9 Market Size (2018-2029)
1.6.3 Asia-Pacific CRISPR & Cas9 Market Size (2018-2029)
1.6.4 Latin America CRISPR & Cas9 Market Size (2018-2029)
1.6.5 Middle East & Africa CRISPR & Cas9 Market Size (2018-2029)
2 CRISPR & Cas9 Market by Type
2.1 Introduction
2.1.1 Genome Editing
2.1.2 Genetic Engineering
2.1.3 gRNA Database/Gene Librar
2.1.4 CRISPR Plasmid
2.1.5 Human Stem Cells
2.1.6 Genetically Modified Organisms/Crops
2.1.7 Cell Line Engineering
2.2 Global CRISPR & Cas9 Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global CRISPR & Cas9 Historic Market Size by Type (2018-2023)
2.2.2 Global CRISPR & Cas9 Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
2.3.2 Europe CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa CRISPR & Cas9 Revenue Breakdown by Type (2018-2029)
3 CRISPR & Cas9 Market Overview by Application
3.1 Introduction
3.1.1 Biotechnology Companies
3.1.2 Pharmaceutical Companies
3.1.3 Academic Institutes
3.1.4 Research and Development Institutes
3.2 Global CRISPR & Cas9 Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global CRISPR & Cas9 Historic Market Size by Application (2018-2023)
3.2.2 Global CRISPR & Cas9 Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
3.3.2 Europe CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa CRISPR & Cas9 Revenue Breakdown by Application (2018-2029)
4 CRISPR & Cas9 Competition Analysis by Players
4.1 Global CRISPR & Cas9 Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2022)
4.3 Date of Key Players Enter into CRISPR & Cas9 Market
4.4 Global Top Players CRISPR & Cas9 Headquarters and Area Served
4.5 Key Players CRISPR & Cas9 Product Solution and Service
4.6 Competitive Status
4.6.1 CRISPR & Cas9 Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Caribou Biosciences
5.1.1 Caribou Biosciences Profile
5.1.2 Caribou Biosciences Main Business
5.1.3 Caribou Biosciences CRISPR & Cas9 Products, Services and Solutions
5.1.4 Caribou Biosciences CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.1.5 Caribou Biosciences Recent Developments
5.2 Integrated DNA Technologies(IDT)
5.2.1 Integrated DNA Technologies(IDT) Profile
5.2.2 Integrated DNA Technologies(IDT) Main Business
5.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Products, Services and Solutions
5.2.4 Integrated DNA Technologies(IDT) CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.2.5 Integrated DNA Technologies(IDT) Recent Developments
5.3 CRISPR Therapeutics
5.3.1 CRISPR Therapeutics Profile
5.3.2 CRISPR Therapeutics Main Business
5.3.3 CRISPR Therapeutics CRISPR & Cas9 Products, Services and Solutions
5.3.4 CRISPR Therapeutics CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck CRISPR & Cas9 Products, Services and Solutions
5.4.4 Merck CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Mirus Bio
5.5.1 Mirus Bio Profile
5.5.2 Mirus Bio Main Business
5.5.3 Mirus Bio CRISPR & Cas9 Products, Services and Solutions
5.5.4 Mirus Bio CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.5.5 Mirus Bio Recent Developments
5.6 Editas Medicine
5.6.1 Editas Medicine Profile
5.6.2 Editas Medicine Main Business
5.6.3 Editas Medicine CRISPR & Cas9 Products, Services and Solutions
5.6.4 Editas Medicine CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.6.5 Editas Medicine Recent Developments
5.7 Takara Bio
5.7.1 Takara Bio Profile
5.7.2 Takara Bio Main Business
5.7.3 Takara Bio CRISPR & Cas9 Products, Services and Solutions
5.7.4 Takara Bio CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.7.5 Takara Bio Recent Developments
5.8 Thermo Fisher Scientific
5.8.1 Thermo Fisher Scientific Profile
5.8.2 Thermo Fisher Scientific Main Business
5.8.3 Thermo Fisher Scientific CRISPR & Cas9 Products, Services and Solutions
5.8.4 Thermo Fisher Scientific CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.8.5 Thermo Fisher Scientific Recent Developments
5.9 Horizon Discovery Group
5.9.1 Horizon Discovery Group Profile
5.9.2 Horizon Discovery Group Main Business
5.9.3 Horizon Discovery Group CRISPR & Cas9 Products, Services and Solutions
5.9.4 Horizon Discovery Group CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.9.5 Horizon Discovery Group Recent Developments
5.10 Intellia Therapeutics
5.10.1 Intellia Therapeutics Profile
5.10.2 Intellia Therapeutics Main Business
5.10.3 Intellia Therapeutics CRISPR & Cas9 Products, Services and Solutions
5.10.4 Intellia Therapeutics CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.10.5 Intellia Therapeutics Recent Developments
5.11 Agilent Technologies
5.11.1 Agilent Technologies Profile
5.11.2 Agilent Technologies Main Business
5.11.3 Agilent Technologies CRISPR & Cas9 Products, Services and Solutions
5.11.4 Agilent Technologies CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.11.5 Agilent Technologies Recent Developments
5.12 Cellecta
5.12.1 Cellecta Profile
5.12.2 Cellecta Main Business
5.12.3 Cellecta CRISPR & Cas9 Products, Services and Solutions
5.12.4 Cellecta CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.12.5 Cellecta Recent Developments
5.13 GenScript
5.13.1 GenScript Profile
5.13.2 GenScript Main Business
5.13.3 GenScript CRISPR & Cas9 Products, Services and Solutions
5.13.4 GenScript CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.13.5 GenScript Recent Developments
5.14 GeneCopoeia
5.14.1 GeneCopoeia Profile
5.14.2 GeneCopoeia Main Business
5.14.3 GeneCopoeia CRISPR & Cas9 Products, Services and Solutions
5.14.4 GeneCopoeia CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.14.5 GeneCopoeia Recent Developments
5.15 Synthego
5.15.1 Synthego Profile
5.15.2 Synthego Main Business
5.15.3 Synthego CRISPR & Cas9 Products, Services and Solutions
5.15.4 Synthego CRISPR & Cas9 Revenue (US$ Million) & (2018-2023)
5.15.5 Synthego Recent Developments
6 North America
6.1 North America CRISPR & Cas9 Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe CRISPR & Cas9 Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific CRISPR & Cas9 Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America CRISPR & Cas9 Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa CRISPR & Cas9 Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 CRISPR & Cas9 Market Dynamics
11.1 CRISPR & Cas9 Industry Trends
11.2 CRISPR & Cas9 Market Drivers
11.3 CRISPR & Cas9 Market Challenges
11.4 CRISPR & Cas9 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List